These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Novel presenilin 1 and 2 double knock-out cell line for in vitro validation of PSEN1 and PSEN2 mutations. Pimenova AA; Goate AM Neurobiol Dis; 2020 May; 138():104785. PubMed ID: 32032730 [TBL] [Abstract][Full Text] [Related]
10. Targeting γ-Secretase for Familial Alzheimer's Disease. Wolfe MS Med Chem Res; 2021 Jul; 30(7):1321-1327. PubMed ID: 35295247 [TBL] [Abstract][Full Text] [Related]
11. Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production. Suárez-Calvet M; Belbin O; Pera M; Badiola N; Magrané J; Guardia-Laguarta C; Muñoz L; Colom-Cadena M; Clarimón J; Lleó A J Neurochem; 2014 Jan; 128(2):330-9. PubMed ID: 24117942 [TBL] [Abstract][Full Text] [Related]
12. Decreased Deposition of Beta-Amyloid 1-38 and Increased Deposition of Beta-Amyloid 1-42 in Brain Tissue of Presenilin-1 E280A Familial Alzheimer's Disease Patients. Dinkel F; Trujillo-Rodriguez D; Villegas A; Streffer J; Mercken M; Lopera F; Glatzel M; Sepulveda-Falla D Front Aging Neurosci; 2020; 12():220. PubMed ID: 32848702 [TBL] [Abstract][Full Text] [Related]
13. AMY plaques in familial AD: comparison with sporadic Alzheimer's disease. Lippa CF; Schmidt ML; Nee LE; Bird T; Nochlin D; Hulette C; Mori H; Lee VM; Trojanowski JQ Neurology; 2000 Jan; 54(1):100-4. PubMed ID: 10636133 [TBL] [Abstract][Full Text] [Related]
14. Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease. Blain JF; Bursavich MG; Freeman EA; Hrdlicka LA; Hodgdon HE; Chen T; Costa DE; Harrison BA; Kapadnis S; Murphy DA; Nolan S; Tu Z; Tang C; Burnett DA; Patzke H; Koenig G Alzheimers Res Ther; 2016 Aug; 8(1):34. PubMed ID: 27572246 [TBL] [Abstract][Full Text] [Related]
15. Alternative processing of γ-secretase substrates in common forms of mild cognitive impairment and Alzheimer's disease: evidence for γ-secretase dysfunction. Hata S; Fujishige S; Araki Y; Taniguchi M; Urakami K; Peskind E; Akatsu H; Araseki M; Yamamoto K; Martins RN; Maeda M; Nishimura M; Levey A; Chung KA; Montine T; Leverenz J; Fagan A; Goate A; Bateman R; Holtzman DM; Yamamoto T; Nakaya T; Gandy S; Suzuki T Ann Neurol; 2011 Jun; 69(6):1026-31. PubMed ID: 21681798 [TBL] [Abstract][Full Text] [Related]
19. Amyloid precursor protein-induced axonopathies are independent of amyloid-beta peptides. Stokin GB; Almenar-Queralt A; Gunawardena S; Rodrigues EM; Falzone T; Kim J; Lillo C; Mount SL; Roberts EA; McGowan E; Williams DS; Goldstein LS Hum Mol Genet; 2008 Nov; 17(22):3474-86. PubMed ID: 18694898 [TBL] [Abstract][Full Text] [Related]
20. Familial Alzheimer's disease mutations in presenilin 1 do not alter levels of the secreted amyloid-beta protein precursor generated by beta-secretase cleavage. Zhang C; Browne A; Kim DY; Tanzi RE Curr Alzheimer Res; 2010 Feb; 7(1):21-6. PubMed ID: 20205669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]